DrugPatentWatch Database Preview
GAMASTAN Drug Profile
» See Plans and Pricing
Patent Text Search: US Patents for GAMASTAN
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Grifols Usa, Llc | GAMASTAN | immune globulin (human) | INJECTION, SOLUTION | 101134 | 1 | 1996-08-14 | Start Trial | Halozyme, Inc. (San Diego, CA) | 2023-03-05 | search | ||
| Grifols Usa, Llc | GAMASTAN | immune globulin (human) | INJECTION, SOLUTION | 101134 | 1 | 1996-08-14 | Start Trial | The Australian National University (Acton, AU) | 2008-09-24 | search | ||
| Grifols Usa, Llc | GAMASTAN | immune globulin (human) | INJECTION, SOLUTION | 101134 | 1 | 1996-08-14 | Start Trial | Acambis, Inc. (Cambridge, MA) | 2017-10-20 | search | ||
| Grifols Usa, Llc | GAMASTAN | immune globulin (human) | INJECTION, SOLUTION | 101134 | 1 | 1996-08-14 | Start Trial | Gilead Sciences, Inc. (Foster City, CA) | 2027-07-06 | search | ||
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for GAMASTAN
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Hong Kong | 1109162 | Start Trial |
| Montenegro | 02631 | Start Trial |
| Taiwan | I533868 | Start Trial |
| Argentina | 106924 | Start Trial |
| Japan | 2008531017 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for GAMASTAN
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 132016000025345 | Italy | Start Trial | PRODUCT NAME: TRASTUZUMAB PER USO SOTTOCUTANEO(HERCEPTIN); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/00/145/002, 20130828 |
| 2016/063 | Ireland | Start Trial | PRODUCT NAME: COBICISTAT OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF AND DARUNAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, IN PARTICULAR DARUNAVIR ETHANOLATE; REGISTRATION NO/DATE: EU/1/14/967 20141119 |
| CR 2016 00031 | Denmark | Start Trial | PRODUCT NAME: RITUXIMAB AND RECOMBINANT HUMAN HYALURONIDASE; NAT. REG. NO/DATE: EU/1/98/067/003-004 20140326; FIRST REG. NO/DATE: EU EU/1/98/067 20140326 |
| 93353 | Luxembourg | Start Trial | PRODUCT NAME: COBICISTAT OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI ET ATAZANAVIR OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI, EN PARTICULIER LE SULFATE D'ATAZANAVIR; AUTHORISATION NUMBER AND DATE: EU/1/15/1025 |
| 2016/062 | Ireland | Start Trial | PRODUCT NAME: COBICISTAT OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND ATAZANAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR ATAZANAVIR SULFATE; REGISTRATION NO/DATE: EU/1/15/1025 20160713 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
